Literature DB >> 2140863

Ocular toxic effects of fenretinide.

M R Modiano1, W S Dalton, S M Lippman, L Joffe, A R Booth, F L Meyskens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2140863     DOI： 10.1093/jnci/82.12.1063

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  3 in total

1.  Phase II study of fenretinide (NSC 374551) in adults with recurrent malignant gliomas: A North American Brain Tumor Consortium study.

Authors:  Vinay K Puduvalli; W K Alfred Yung; Kenneth R Hess; John G Kuhn; Morris D Groves; Victor A Levin; James Zwiebel; Susan M Chang; Timothy F Cloughesy; Larry Junck; Patrick Wen; Frank Lieberman; Charles A Conrad; Mark R Gilbert; Christina A Meyers; Vivien Liu; Minesh P Mehta; M Kelly Nicholas; Michael Prados
Journal:  J Clin Oncol       Date:  2004-11-01       Impact factor: 44.544

2.  Total rod ERG suppression with high dose compassionate Fenretinide usage.

Authors:  Michael F Marmor; Atul Jain; Darius Moshfeghi
Journal:  Doc Ophthalmol       Date:  2008-06-04       Impact factor: 2.379

Review 3.  Risks and benefits of retinoids in the chemoprevention of cancer.

Authors:  G de Palo; F Formelli
Journal:  Drug Saf       Date:  1995-10       Impact factor: 5.606
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.